chinese imports 301 tariffs

Updated May 8, 2020
On Mar. 25, 2020, the Office of the U.S. Trade Representative (USTR) published a notice requesting comments on possible removal of duties medical-care products needed to address the COVID-19 outbreak. The docket for comments will be open at least until June 25, 2020 but may be extended.
On Mar. 22, 2018, President Trump signed a memorandum announcing that the United States would take multiple steps to protect American technology and intellectual property from certain discriminatory and burdensome trade practices by China.

These actions were announced following a Section 301 report by the Office of the U.S. Trade Representative (USTR) regarding China’s acts, policies and practices with respect to technology transfer, intellectual property and innovation.

USTR has published four tariff lists since June 2018 of products imported from China that would be subject to an additional tariff. Additional information can be found below.

U.S.-China Phase-One Agreement

On Dec. 13, 2019, USTR announced that the U.S. had reached a phase-one trade agreement with China in areas of intellectual property, technology transfer, agriculture, financial services, and currency and foreign exchange. The agreement also includes China's commitment to purchase U.S. goods and services. More information can be found in the fact sheet.

For more information or questions, please contact Angela Chiang at

Section 301 Resources

+ How to Navigate the Section 301 Tariffs

+ List 1 Tariffs & Exclusions

+ List 2 Tariffs & Exclusions

+ List 3 Tariffs & Exclusions

+ List 4 Tariffs & Exclusions

  • Share